Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
BOSTON–(BUSINESS WIRE)–Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.
We are focused on advancing the development…
